AnalystsReni J. Benjamin
Reni J. Benjamin's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 23%
#4119 out of 5337 analysts
Average Return
-0.12%
Win Rate
36%10 out of 28
Risk vs Reward
Poor
Good

Reni J. Benjamin's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prelude Therapeutics IncPRLD
+391.53%$0.94$4.64
2025-08-18 -
2026-07-28
Buy
Kura Oncology IncKURA
+68.05%$5.54$9.31
2025-08-11 -
2026-07-28
Buy
Bicara Therapeutics IncBCAX
+58.96%$16.91$26.88
2026-01-29 -
2026-07-28
Buy
Bicara Therapeutics IncBCAX
+35.14%$19.89$26.88
2026-03-31 -
2026-07-28
Buy
Iovance Biotherapeutics IncIOVA
+25.50%$3.75$4.70
2026-03-03 -
2026-07-28
Buy

Reni J. Benjamin Analyst Color

Get additional color on Reni J. Benjamin's coverage of popular stocks

Reni J. Benjamin's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Beone Medicines LtdONC
2Buy$396.00+19.83%Reiterates
a month ago
Lyell Immunopharma IncLYEL
2Buy$34.00+161.74%Reiterates
a month ago
Kura Oncology IncKURA
3Buy$24.00+157.79%Reiterates
a month ago
Compass Therapeutics IncCMPX
1Buy$10.00+390.20%Reiterates
3 months ago
Sutro Biopharma IncSTRO
2Buy$41.00+72.78%Maintains
3 months ago
Whitehawk Therapeutics IncWHWK
1Buy$8.00+117.39%Initiates Coverage On
3 months ago
Allogene Therapeutics IncALLO
1Buy$8.00+381.93%Maintains
3 months ago
Bicara Therapeutics IncBCAX
2Buy$31.00+15.33%Reiterates
4 months ago
IMMIX Biopharma IncIMMX
1Buy$23.00+172.51%Reiterates
4 months ago
Iovance Biotherapeutics IncIOVA
2Buy$5.00+6.38%Upgrades
5 months ago
Immutep LtdIMMP
2Buy$10.00+2,483.98%Initiates Coverage On
5 months ago
Summit Therapeutics IncSMMT
4Buy$40.00+218.73%Reiterates
6 months ago
Zymeworks IncZYME
1Buy$32.00+41.53%Initiates Coverage On
8 months ago
Sana Biotechnology IncSANA
1Buy$8.00+143.16%Maintains
9 months ago
Werewolf Therapeutics IncHOWL
1Buy$3.00+568.15%Maintains
a year ago
Prelude Therapeutics IncPRLD
1Buy$3.00-35.34%Maintains
a year ago
Bicycle Therapeutics PLCBCYC
1Buy$10.00+153.81%Maintains
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.